Health
ERS Genomics Appoints Michael Arciero As Vice-President of Intellectual Property & Commercial Development – Technology Networks
Michael previously led the technology transfer team at USC Stevens Center for Innovation in his capacity as Director of Technology Commercialisation.
ERS Genomics Limited (ERS), which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr. Emmanuelle Charpentier, today announced the appointment of Michael Arciero as Vice-President of Intellectual Property and Commercial Development. In the new role, Michael will oversee the intellectual property portfolio of the company and will become a core member of the Company’s global business development team.Michael has over 15 years of experience i…
-
General20 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News24 hours agoSouth-west Queensland highway closed after truck carrying oxygen cylinders catches fire
-
General21 hours agoLithium mine closure shines light on Ravensthorpe community’s resilience
-
General22 hours agoBack-to-back rate cuts tipped when Reserve Bank meets